Literature DB >> 215538

Prolonged prostaglandin E1 stimulation of cyclic AMP production in transformed and normal WI-38 fibroblasts.

F J Chlapowski, K P Ray, R W Butcher.   

Abstract

Long-term (48-hr) incubations of either the fibroblast strain WI-38 or its SV40-transformed counterpart, WI-38-VA13-2RA, in growth medium containing 1 micron prostaglandin E1 (PGE1) resulted in a sustained production and release of cyclic AMP from the cells into the medium. Despite the steady production, intracellular levels of the nucleotide decreased, reaching steady-state values within 4 hr of the initial exposure to PGE1. These values were maintained for the remainder of the 48-hr experimental period. The steady-state levels of intracellular cyclic AMP were higher than those observed in unstimulated cells, and cyclic AMP-dependent protein phosphokinase was in a highly activated state as compared to controls. Under these conditions little change in the growth or morphology of either the normal or transformed cells was observed. In contrast, inhibition of growth, apparent cell death, and unusual morphological changes were observed in both normal and transformed cells when high concentrations of either PGE1 (10 micron) or the phosphodiesterase inhibitor 1-methyl, 3-isobutylxanthine (0.5 mM to 2 mM) were used, which was indicative of toxic effects of the drugs. It was concluded that cyclic AMP-mediated activation of protein phosphokinase does not completely inhibit growth in WI-38 cells or restore normal growth and morphology to the SV40-transformed cells.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 215538     DOI: 10.1007/bf02616122

Source DB:  PubMed          Journal:  In Vitro        ISSN: 0073-5655


  20 in total

Review 1.  Role of cyclic nucleotides in growth control.

Authors:  I H Pastan; G S Johnson; W B Anderson
Journal:  Annu Rev Biochem       Date:  1975       Impact factor: 23.643

2.  Cyclic adenosine 3':5'-monophosphate metabolism in normal and SV40-transformed WI-38 cells.

Authors:  L A Kelly; M S Hall; R W Butcher
Journal:  J Biol Chem       Date:  1974-08-25       Impact factor: 5.157

3.  Subcellular distribution of adenyl cyclase and phosphodiesterase in Acanthamoeba palestinensis.

Authors:  F J Chlapowski; R W Butcher
Journal:  Biochim Biophys Acta       Date:  1973-05-05

4.  SV40 transformation of human diploid cells. A parallel study of viral and karyologic parameters.

Authors:  A J Girardi; D Weinstein; P S Moorhead
Journal:  Ann Med Exp Biol Fenn       Date:  1966

5.  A simple method for the preparation of 32-P-labelled adenosine triphosphate of high specific activity.

Authors:  I M Glynn; J B Chappell
Journal:  Biochem J       Date:  1964-01       Impact factor: 3.857

6.  Growth of astrocytoma cells in the presence of prostaglandin E1: effect on the regulation of cyclic AMP metabolism.

Authors:  B H Leichtling; A M Drotar; R Ortmann; J P Perkins
Journal:  J Cyclic Nucleotide Res       Date:  1976

7.  Regulation of phosphodiesterase synthesis: requirement for cyclic adenosine monophosphate-dependent protein kinase.

Authors:  H R Bourne; G M Tomkins; S Dion
Journal:  Science       Date:  1973-09-07       Impact factor: 47.728

8.  Prostaglandin E 1 effects on adenosine 3':5'-cyclic monophosphate concentration and phosphodiesterase activity in fibroblasts (mouse L cells-tissue culture-enzyme kinetics-prostaglandin homologues).

Authors:  V Maganiello; M Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

9.  Regulation of adenosine 3',5'-cyclic monophosphate phosphodiesterase activity in fibroblasts by intracellular concentrations of cyclic adenosine monophosphate (3T3-dibutyryl cyclic AMP-SV40-transformed cells-michaelis constants-L cells-prostaglandin E 1 ).

Authors:  M D'Armiento; G S Johnson; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1972-02       Impact factor: 11.205

Review 10.  The role of adenosine 3',5'-cyclic monophosphate in the regulation of mammalian cell division.

Authors:  C W Abell; T M Monahan
Journal:  J Cell Biol       Date:  1973-12       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.